HYPERTENSIVE DOCA/NACL RATS EXHIBIT REDUCED PRESSOR-RESPONSE TO THE SPECIFIC DOPAMINE (D2) AGONIST, LY171555

被引：0

作者：

CHEN, YF ^{[1
]}

NAGAHAMA, S ^{[1
]}

OPARIL, S ^{[1
]}

机构：

[1] UNIV ALABAMA, CARDIOVASC RES & TRAINING CTR, BIRMINGHAM, AL 35294 USA

来源：

CLINICAL RESEARCH | 1986年 / 34卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：A188 / A188

页数：1

共 31 条

[1] THE SPECIFIC DOPAMINE AGONIST, LY171555, SELECTIVELY INCREASES DOPAMINE CONTENT OF ANTERIOR HYPOTHALAMUS IN DOCA/NACL HYPERTENSIVE RAT
CHEN, YF
JIN, HK
GIST, R
OPARIL, S
CLINICAL RESEARCH, 1986, 34 (01): : A188 - A188
[2] CONSCIOUS DOCA/NACL HYPERTENSIVE RATS EXHIBIT A BLUNTED PRESSOR-RESPONSE TO THE DOPAMINE D2 AGONIST QUINPIROLE IN THE PRESENCE OF ENHANCED SYMPATHOADRENAL DISCHARGE
CHEN, YF
JIN, HK
OPARIL, S
CLINICAL RESEARCH, 1987, 35 (01): : A16 - A16
[3] THE SPECIFIC DOPAMINE AGONIST, LY171555, SELECTIVELY INCREASES DOPAMINE CONTENT OF ANTERIOR HYPOTHALAMUS IN DOCA/NACL HYPERTENSIVE RAT
OPARIL, S
JIN, HK
GIST, R
CHEN, YF
FEDERATION PROCEEDINGS, 1986, 45 (03) : 194 - 194
[4] ENHANCED RESPONSE TO THE INHIBITORY-ACTION OF LY171555, A DOPAMINE D2-AGONIST, ON INVIVO STRIATAL DOPAMINE RELEASE IN DOCA/NACL-HYPERTENSIVE RATS
CHEN, YF
OPARIL, S
BRAIN RESEARCH, 1987, 400 (02) : 225 - 231
[5] LY171555, A SELECTIVE DOPAMINE D2 RECEPTOR AGONIST, INHIBITS INVIVO STRIATAL DOPAMINE RELEASE IN NORMOTENSIVE AND HYPERTENSIVE RATS
CHEN, YF
OPARIL, S
CLINICAL RESEARCH, 1986, 34 (01): : A177 - A177
[6] THE SPECIFIC DOPAMINE AGONIST, LY171555, DECREASES NOREPINEPHRINE CONTENT OF POSTERIOR HYPOTHALAMUS IN THE NORMOTENSIVE RAT BUT NOT IN THE DOCA/NACL HYPERTENSIVE RAT
CHEN, YF
JIN, HK
GIST, R
OPARIL, S
CLINICAL RESEARCH, 1986, 34 (01): : A218 - A218
[7] THE SPECIFIC DOPAMINE AGONIST, LY171555, DECREASES NOREPINEPHRINE CONTENT OF POSTERIOR HYPOTHALAMUS IN THE NORMOTENSIVE RAT BUT NOT IN THE DOCA/NACL HYPERTENSIVE RAT
CHEN, YF
JIN, HK
GIST, R
OPARIL, S
FEDERATION PROCEEDINGS, 1986, 45 (03) : 194 - 194
[8] MECHANISM OF THE PRESSOR ACTION OF LY171555, A SPECIFIC DOPAMINE-D2 RECEPTOR AGONIST, IN THE CONSCIOUS RAT
NAGAHAMA, S
CHEN, YF
LINDHEIMER, MD
OPARIL, S
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 236 (03): : 735 - 742
[9] THE D2 DOPAMINE RECEPTOR AGONIST LY171555 INDUCES CATALEPSY IN THE MOUSE
PUGLISIALLEGRA, S
CABIB, S
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 30 (03) : 765 - 768
[10] RAPID DESENSITIZATION OF THE CENTRAL PRESSOR ACTION OF LY171555, A SPECIFIC DOPAMINE-D2 RECEPTOR AGONIST IN CONSCIOUS RAT
IGARASHI, Y
CHEN, YF
WYSS, JM
CLINICAL RESEARCH, 1986, 34 (02): : A400 - A400

← 1 2 3 4 →